PSAT385 Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer

por Vodopivec, Danica M, Cabanillas, Maria E, Busaidy, Naifa L, Gule-Monroe, Maria K, Zafereo, Mark E, Wang, Jennifer R, Williams, Michelle D, Waguespack, Steven G, Bassett, Roland, Maniakas, Anastasios, Lai, Stephen Y, Dadu, Ramona
Publicado 2022

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAF(V600E)-Mutated Anaplastic Thyroid Carcinoma

por Wang, Jennifer R., Zafereo, Mark E., Dadu, Ramona, Ferrarotto, Renata, Busaidy, Naifa L., Lu, Charles, Ahmed, Salmaan, Gule-Monroe, Maria K., Williams, Michelle D., Sturgis, Erich M., Goepfert, Ryan P., Gross, Neil D., Lai, Stephen Y., Gunn, Gary Brandon, Phan, Jack, Rosenthal, David I., Fuller, Clifton David, Morrison, William H., Iyer, Priyanka, Cabanillas, Maria E.
Publicado 2019

Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression

por Cao, Shaolong, Wang, Jennifer R., Ji, Shuangxi, Yang, Peng, Dai, Yaoyi, Guo, Shuai, Montierth, Matthew D., Shen, John Paul, Zhao, Xiao, Chen, Jingxiao, Lee, Jaewon James, Guerrero, Paola A., Spetsieris, Nicholas, Engedal, Nikolai, Taavitsainen, Sinja, Yu, Kaixian, Livingstone, Julie, Bhandari, Vinayak, Hubert, Shawna M., Daw, Najat C., Futreal, P. Andrew, Efstathiou, Eleni, Lim, Bora, Viale, Andrea, Zhang, Jianjun, Nykter, Matti, Czerniak, Bogdan A., Brown, Powel H., Swanton, Charles, Msaouel, Pavlos, Maitra, Anirban, Kopetz, Scott, Campbell, Peter, Speed, Terence P., Boutros, Paul C., Zhu, Hongtu, Urbanucci, Alfonso, Demeulemeester, Jonas, Van Loo, Peter, Wang, Wenyi
Publicado 2022